| P50 | author | Roberto M La Ragione | Q42406209 |
| | Mark Chambers | Q53342381 |
| | Simon P. Graham | Q40074007 |
| P2860 | cites work | Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines | Q42253606 |
| | Deduced sequences of the membrane fusion and attachment proteins of canine distemper viruses isolated from dogs and wild animals in Korea | Q42265013 |
| | Porcine reproductive and respiratory syndrome virus: genetic diversity of recent British isolates | Q42283621 |
| | Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses | Q42596552 |
| | Genetic variation of Chinese PRRSV strains based on ORF5 sequence | Q42601017 |
| | Molecular characterization of recent Korean porcine reproductive and respiratory syndrome (PRRS) viruses and comparison to other Asian PRRS viruses | Q42689372 |
| | Detection of cytopathic bovine viral diarrhea virus in the ovaries of cattle following immunization with a modified live bovine viral diarrhea virus vaccine | Q42987844 |
| | Induction of humoral and cellular immune responses in mice by a recombinant fowlpox virus expressing the E2 protein of bovine viral diarrhea virus | Q42992484 |
| | Expression of the E2 envelope glycoprotein of bovine viral diarrhoea virus (BVDV) elicits virus-type specific neutralising antibodies | Q42992491 |
| | Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses | Q42995077 |
| | Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs | Q42995430 |
| | Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. | Q42996041 |
| | Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation | Q42999977 |
| | Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats | Q43001296 |
| | DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge | Q43047647 |
| | Humoral Immune Response and Assessment of Vaccine Virus Shedding in Calves Receiving Modified Live Virus Vaccines Containing Bovine Herpesvirus‐1 and Bovine Viral Diarrhoea Virus 1a | Q43048811 |
| | DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge | Q43048822 |
| | Oral immunisation of laying hens with the live vaccine strains of TAD Salmonella vac E and TAD Salmonella vac T reduces internal egg contamination with Salmonella Enteritidis | Q43220951 |
| | Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand | Q44119303 |
| | Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes | Q44326368 |
| | Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. | Q44335250 |
| | Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity | Q45024784 |
| | Predictive markers of safety and immunogenicity of adjuvanted vaccines | Q45057515 |
| | Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies | Q45366717 |
| | Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge. | Q45373686 |
| | Frequency of PRRS live vaccine virus (European and North American genotype) in vaccinated and non-vaccinated pigs submitted for respiratory tract diagnostics in North-Western Germany | Q45381962 |
| | In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus | Q45382377 |
| | GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge | Q45384291 |
| | Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus | Q45394061 |
| | Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus | Q45394570 |
| | Effect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infection | Q45404561 |
| | Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. | Q45405380 |
| | Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus | Q45413217 |
| | Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus | Q45447879 |
| | The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus | Q45559394 |
| | DNA vaccination of pigs with open reading frame 1-7 of PRRS virus | Q45599373 |
| | Gradual development of the interferon-γ response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination | Q45723769 |
| | Fish DNA vaccine against infectious hematopoietic necrosis virus: efficacy of various routes of immunisation | Q45738663 |
| | Changes of leukocyte phenotype and function in the broncho-alveolar lavage fluid of pigs infected with porcine reproductive and respiratory syndrome virus: a role for CD8(+) cells | Q45744931 |
| | IFN gamma inhibits porcine reproductive and respiratory syndrome virus replication in macrophages | Q45747833 |
| | Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants | Q45761038 |
| | Cell-Mediated Immunity to Porcine Reproductive and Respiratory Syndrome Virus in Swine | Q45762042 |
| | Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses | Q46352766 |
| | Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys. | Q46490934 |
| | Characterization of the invasiveness of monophasic and aphasic Salmonella Typhimurium strains in 1-day-old and point-of-lay chickens | Q46897335 |
| | Scientific Opinion on field trials for bovine tuberculosis vaccination | Q47154003 |
| | Estimation of the impact of vaccination on faecal shedding and organ and egg contamination for Salmonella Enteritidis, Salmonella Typhiumurium and monophasic Salmonella Typhimurium | Q50000800 |
| | Duration of immunity induced in chickens by an attenuated live Salmonella enteritidis vaccine and an inactivated Salmonella enteritidis/typhimurium vaccine | Q50042635 |
| | The rise and fall of Salmonella Enteritidis in the UK. | Q50104436 |
| | A laboratory study of an inactivated bivalent iron restricted Salmonella enterica serovars Enteritidis and Typhimurium dual vaccine against Typhimurium challenge in chickens | Q50107296 |
| | Oral vaccination of badgers (Meles meles) against tuberculosis: comparison of the protection generated by BCG vaccine strains Pasteur and Danish. | Q50561452 |
| | Veterinary and human vaccine evaluation methods. | Q55113282 |
| | Exposure of nontarget wildlife to candidate TB vaccine baits deployed for European badgers | Q56933186 |
| | Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums | Q58433112 |
| | Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial | Q58853389 |
| | Absorption of Mycobacterium bovis BCG administered by the oral route | Q68167033 |
| | Salmonella enteritidis epidemic | Q73650191 |
| | Feline vaccine-associated sarcomas | Q73941290 |
| | Oral vaccination of brushtail possums with BCG: Investigation into factors that may influence vaccine efficacy and determination of duration of protection | Q79210515 |
| | Efficacy of oral and parenteral routes of Mycobacterium bovis bacille Calmette-Guerin vaccination against experimental bovine tuberculosis in white-tailed deer (Odocoileus virginianus): a feasibility study | Q81152550 |
| | Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs | Q82276754 |
| | Modelling collective effectiveness of voluntary vaccination with and without incentives | Q82294213 |
| | Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant | Q82416184 |
| | Farmers' confidence in vaccinating badgers against bovine tuberculosis | Q83215598 |
| | Developing the next generation of vaccines | Q86963418 |
| | Serological titers to bovine herpesvirus 1, bovine viral diarrhea virus, parainfluenza 3 virus, bovine respiratory syncytial virus and Pasteurella haemolytica in feedlot calves with respiratory disease: associations with bacteriological and pulmonar | Q27472682 |
| | Current Status of Veterinary Vaccines | Q27480923 |
| | Evolution of the TIR, tolls and TLRs: functional inferences from computational biology | Q28216685 |
| | Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis | Q28740383 |
| | Influenza vaccines and vaccination strategies in birds. | Q30364756 |
| | Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. | Q30830088 |
| | Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7. | Q33204572 |
| | First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. | Q33502406 |
| | Vaccination of cattle against bovine viral diarrhoea | Q33535495 |
| | Salmonella enterica serovar Enteritidis, England and Wales, 1945-2011 | Q33816281 |
| | Equine vaccination | Q33884219 |
| | The effects of bovine viral diarrhoea virus on cattle reproduction in relation to disease control | Q33938020 |
| | Adjuvants designed for veterinary and human vaccines | Q34189235 |
| | Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges | Q34432119 |
| | Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies | Q34545996 |
| | Recombination in vaccine and circulating strains of porcine reproductive and respiratory syndrome viruses | Q34603663 |
| | A behaviorally-explicit approach for delivering vaccine baits to mesopredators to control epizootics in fragmented landscapes | Q34960321 |
| | Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. | Q34982599 |
| | Predicting the public health benefit of vaccinating cattle against Escherichia coli O157 | Q34991352 |
| | Bacterial ghosts as vaccine candidates for veterinary applications. | Q35024808 |
| | Paratuberculosis vaccination causes only limited cross-reactivity in the skin test for diagnosis of bovine tuberculosis | Q35058530 |
| | Recent advances in veterinary vaccine adjuvants | Q35143257 |
| | Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. | Q35690037 |
| | Strategies for improved formulation and delivery of DNA vaccines to veterinary target species | Q35826384 |
| | Role of neutralizing antibodies in PRRSV protective immunity | Q35928806 |
| | Elimination of terrestrial rabies in Western European countries | Q36061791 |
| | Challenges and constraints to vaccination in developing countries. | Q38442974 |
| | Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines | Q39095039 |
| | Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2. | Q39427739 |
| | Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization. | Q39496965 |
| | Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. | Q39613411 |
| | Comparative genomic analysis of five pairs of virulent parental/attenuated vaccine strains of PRRSV | Q39626852 |
| | Potential of cooperation between human and animal health to strengthen health systems | Q39632815 |
| | CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine | Q39654303 |
| | Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus | Q39853959 |
| | Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus | Q39880592 |
| | Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene | Q39987306 |
| | The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies | Q40017444 |
| | Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus | Q40057544 |
| | Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). | Q40166458 |
| | Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle | Q40233646 |
| | Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10. | Q40259551 |
| | Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro | Q40349556 |
| | Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle | Q40446696 |
| | The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. | Q40644350 |
| | Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture. | Q40774685 |
| | Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine | Q40807962 |
| | Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses | Q40937268 |
| | Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus | Q41039810 |
| | Cytokines as adjuvants for ruminant vaccines | Q41219314 |
| | Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease | Q41247560 |
| | Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus | Q41252922 |
| | Approaches towards DNA vaccination against a skin ciliate parasite in fish. | Q41376422 |
| | A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera | Q41458833 |
| | Adjuvants--a classification and review of their modes of action | Q41461373 |
| | Functional impairment of PRRSV-specific peripheral CD3+CD8high cells | Q41781830 |
| | Assessment of an oral Mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms of adverse reactions, vaccine strain survival, and uptake by nontarget species | Q41907778 |
| | A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains | Q42085923 |
| | A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China | Q42216742 |
| | Proteome-wide screening of the European porcine reproductive and respiratory syndrome virus reveals a broad range of T cell antigen reactivity | Q42217657 |
| | Commercialization of plant-based vaccines from research and development to manufacturing | Q36177373 |
| | The biology of avian Eimeria with an emphasis on their control by vaccination. | Q36288528 |
| | Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity. | Q36307972 |
| | Development of cattle TB vaccines in the UK. | Q36471916 |
| | The "decline and fall" of nontyphoidal salmonella in the United kingdom. | Q36584923 |
| | Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. | Q36678092 |
| | Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors | Q36715877 |
| | The nature and consequences of intra- and inter-vaccine interference | Q36846055 |
| | Mass vaccination and herd immunity: cattle and buffalo. | Q36882960 |
| | The challenge of PRRS immunology. | Q36888431 |
| | Economics of animal vaccination | Q36950226 |
| | Rinderpest: the veterinary perspective on eradication | Q37037384 |
| | An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus | Q37123468 |
| | Vaccine adjuvants: current challenges and future approaches. | Q37244036 |
| | Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis | Q37274874 |
| | Advances in antiviral vaccine development | Q37292398 |
| | Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012. | Q37335186 |
| | Vaccination of birds other than chickens and turkeys against avian influenza. | Q37556431 |
| | Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control? | Q37730660 |
| | GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution | Q37788337 |
| | Molecular epidemiology of PRRSV: a phylogenetic perspective | Q37788341 |
| | Vaccine production in plant systems — An aid to the control of viral diseases in domestic animals: A review | Q37810695 |
| | Immunoglobulin genetics and antibody responses to influenza in ducks | Q37850101 |
| | Advances in fish vaccine delivery | Q37854143 |
| | Update on vaccination of cattle and wildlife populations against tuberculosis. | Q37855175 |
| | DIVA reagents for bovine tuberculosis vaccines in cattle | Q37909428 |
| | Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). | Q37934055 |
| | Bovine tuberculosis vaccine research: historical perspectives and recent advances. | Q37985287 |
| | Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7--a systematic review and meta-analysis | Q38031556 |
| | The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria | Q38076545 |
| | Veterinary vaccines from transgenic plants: highlights of two decades of research and a promising example | Q38080186 |
| | Edible vaccines against veterinary parasitic diseases--current status and future prospects | Q38088890 |
| | Control of bovine ringworm by vaccination in Norway | Q38109721 |
| | Challenges and recent advancements in infectious laryngotracheitis virus vaccines. | Q38110339 |
| | Securing poultry production from the ever-present Eimeria challenge. | Q38163160 |
| | Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus | Q38321106 |
| | Evaluation of Salmonella-vectored Campylobacter peptide epitopes for reduction of Campylobacter jejuni in broiler chickens | Q38429315 |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 33 | |
| P304 | page(s) | 3-35 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Challenges in Veterinary Vaccine Development and Immunization | |
| P478 | volume | 1404 | |